Stock comparison
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MEDP is larger
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B).
Market value leader
MEDP
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B).
Revenue leader
CRL
CRL: $4.02B vs MEDP: $2.53B.
Profit leader
MEDP
CRL: -$144.34M vs MEDP: $451.12M.
Margin leader
MEDP
CRL: -3.6% vs MEDP: 17.8% net margin.
| Metric | CRL | MEDP |
|---|---|---|
| Market cap | $11.25 B | $15.29 B |
| US-listed rank | #889 | #731 |
| Revenue (latest FY) | $4.02B | $2.53B |
| Net income (latest FY) | -$144.34M | $451.12M |
| Net margin | -3.6% | 17.8% |
| P/E (trailing FY) | - | 33.9x |
| SEC filings | 2,387 | 874 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B).
In their latest fiscal years, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B in revenue while Medpace Holdings, Inc. reported $2.53B.
Full pages: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and Medpace Holdings, Inc., or browse the full rankings.